BSE Live
Apr 20, 16:01Prev. Close
893.95
Open Price
890.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 20, 15:55Prev. Close
893.85
Open Price
892.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
912.40 (39)
| Cash Flow of Senores Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 70.57 | 24.94 | 12.44 | 1.14 | |
| Net CashFlow From Operating Activities | -45.92 | -19.87 | -1.08 | -10.45 | |
| Net Cash Used In Investing Activities | -429.48 | -54.66 | -48.29 | -24.44 | |
| Net Cash Used From Financing Activities | 573.13 | 86.98 | 46.25 | 36.46 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 97.73 | 12.45 | -3.12 | 1.58 | |
| Cash And Cash Equivalents Begin of Year | 7.65 | 0.60 | 3.22 | 1.64 | |
| Cash And Cash Equivalents End Of Year | 105.38 | 13.06 | 0.10 | 3.22 |
21.01.2026
Senores Pharma Standalone December 2025 Net Sales at Rs 28.76 crore, up 199.9% Y-o-Y
16.12.2025
12.11.2025
Senores Pharma Standalone September 2025 Net Sales at Rs 35.33 crore, up 266.87% Y-o-Y
07.11.2025
Senores Pharma Consolidated September 2025 Net Sales at Rs 161.76 crore, down 10.24% Y-o-Y
21.01.2026
Senores Pharma Standalone December 2025 Net Sales at Rs 28.76 crore, up 199.9% Y-o-Y
12.11.2025
Senores Pharma Standalone September 2025 Net Sales at Rs 35.33 crore, up 266.87% Y-o-Y
07.11.2025
Senores Pharma Consolidated September 2025 Net Sales at Rs 161.76 crore, down 10.24% Y-o-Y
24.07.2025
Senores Pharma Standalone June 2025 Net Sales at Rs 19.82 crore, up 164.97% Y-o-Y